-
Mashup Score: 1
Introduction According to evidence‐based clinical practice guidelines, patients presenting with disabling stroke symptoms should be treated with intravenous tissue plasminogen activator (IV tPA) wit…
Source: Wiley Online LibraryCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0Is There a Need for tPA Before Thrombectomy in Stroke? - 3 year(s) ago
The MR CLEAN NO IV trial, the latest to investigate this issue, failed to show superiority or noninferiority of dropping thrombolysis before endovascular therapy, and functional outcomes were similar.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The 2 reperfusion therapies of proven benefit for acute ischemic stroke, mechanical endovascular thrombectomy (EVT) and pharmacologic intravenous thrombolysis (IVT), have complementary advantages. EVT, which involves mechanical debulking, works well for accessible sizeable thrombi that occlude large…
Source: jamanetwork.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 23
Background and Purpose: Accumulating evidence from randomized controlled clinical trials suggests that tenecteplase may represent an effective treatment alternative to alteplase for acute ischemic st
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0News: Reanalysis Fires Up Controversy about Alteplase for... : Emergency Medicine News - 4 year(s) ago
An abstract is unavailable.
Source: LWWCategories: Emergency Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke | NEJM - 4 year(s) ago
Original Article from The New England Journal of Medicine — Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke
Source: New England Journal of MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 9Thrombectomy Alone Noninferior to Combination Therapy in Stroke - 4 year(s) ago
Although results of the DIRECT-MT trial did show noninferiority with the combination of thrombolysis and thrombectomy, they do not rule out a benefit of alteplase, researchers conclude.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet
In select patients with wake-up #stroke: Intravenous #alteplase is associated with a better functional outcome at 90 days despite the increased but acceptable risk of sICH. @brianmacgrory @eva_mistry @schrag_matthew @mobilestroke4U @BrownNeurology https://t.co/qcaBrW8a8w